OVID 0.79 (-75.99%)
US6904691010BiotechnologyBiotechnology

Ovid Therapeutics (OVID) Financial Metrics

This table shows a selected set of financial data points of Ovid Therapeutics (OVID). You can choose which elements to display by selecting the desired chart and column.

MarketCap

Total Revenue

Free CashFlow

Year EPS Dividend Yield PE Ratio MarketCap Return On Assets Total Revenue Free CashFlow EBITDA Net Income Cash
2023 -0.74 0 -4.34 227.27M -0.35 391.7K -45.92M -59.69M -52.34M 27.04M
2022 -0.77 0 -2.42 130.99M -0.31 1.5M -56.65M -54.17M -54.17M 44.87M
2021 1.82 0 1.76 216.61M 0.91 208.38M 118.42M 124.45M 122.83M 187.8M
2020 -1.39 0 -1.67 135.02M -1.03 12.62M -51.97M -81.12M -81.04M 72.03M
2019 -1.54 0 -2.69 162.75M -0.94 0 -51.33M -61.41M -60.46M 41.9M
2018 -2.11 0 -1.15 59.61M -0.76 0 -45.91M -51.84M -51.98M 36.49M
2017 -3.35 0 -2.95 190.93M -0.91 0 -31.52M -64.73M -64.81M 87.13M
2016 -1.14 0 0 0 -0.36 0 -17.99M -22.36M -22.41M 51.94M
2015 -0.67 0 0 0 -0.35 0 -5.54M -13.15M -13.16M 69.94M
2014 -0.04 0 0 0 0 0 0 0 -446.89K 4.85M

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.